Netrin-4 (NTN4)

Netrin-4 (NTN4) is a secreted laminin-related protein belonging to the netrin family, distinguished by its role in the extracellular matrix, especially the basement membrane. Netrin-4 regulates multiple biological processes including axonal guidance during neural development, endothelial tube formation, and vascular biology, largely through its ability to bind with high affinity to the laminin γ1 chain, thus disrupting or destabilizing laminin networks and basement membranes[1][2][3]. Unlike other netrins, Netrin-4 does not directly interact with classic netrin receptors (DCC, UNC5), but instead exerts non-enzymatic, structural effects on the extracellular matrix, impacting processes such as axon outgrowth, angiogenesis, and possibly tumor suppression or promotion depending on cellular context[1][2]. Netrin-4 expression and function are context-dependent and have been implicated in cancer biology (as both suppressor and facilitator of tumor progression), vascular disease, neurodegeneration, and inflammation[2]. There are currently no known drugs directly targeting Netrin-4, and its mechanisms of action are largely structural and regulatory within the extracellular matrix, rather than receptor-mediated intracellular signaling[1][2]. Biomarker potential exists in cancer prognosis and angiogenesis monitoring[2]. The main safety considerations for pharmacological modulation of Netrin-4 focus on its fundamental roles in vascular and neural integrity as well as its pleiotropic effects in disease states.

Other names

Netrin-4NTN4beta-netrinhepar-derived netrin-like proteinPRO3091